09.04.2012
“Pharmassets” company was allowed to gain permission for clinical researches of the Letrozole 2,5 mg tablet drug. Date of allowing: 04.04.2012
21.03.2012
“Pharmassets” company was allowed to gain permission for clinical researches of the Fluticasone nasal spray. Date of allowing: 20.03.2012
20.03.2012
“Pharmassets” company was allowed to gain permission for clinical researches of the Glimepiride tablet drug. Date of allowing: 05.03.2012
20.03.2012
“Pharmassets” company is the focus of the pharmaceutical press due to its innovation and advanced development, which was confirmed by "Pharmaceutical Journal" in № 8 from March 6, 2012, in the article named “Pharmassets” on three hits”.
19.03.2012
“Pharmassets” company was allowed to gain permission for clinical researches of the Memantine tablet drug. Date of allowing: 07.03.2012
18.03.2012
“Pharmassets” company was allowed to gain permission for clinical researches of the Metformin tablet drug. Date of allowing: 07.03.2012. For further information about registered preparations visit "Drugs" section.
12.03.2012
The "Pharmassets" company has successfully completed the procedure of state registration of the Medsikam ® (INN: Meloxicam) 7.5 mg and 15 mg tablets. The first drug fully passed the procedure of state registration in accordance with the requirements of the Federal Law № 61-FZ of 12.04.2010 "On the handling of medicines." 7.5 mg and 15 mg tablets - the first medicine fully passed the procedure of state registration in accordance with the requirements of the Federal Law № 61-FZ from 12.04.2010 "On medicines handling." State registration date: 20.12.2011. Registration Certificate Number: LP-001 373. For further information about registered preparations visit "Registered preparations" section.
06.03.2012
“Pharmassets” company gained permission for clinical researches of the Imipenem + Cilastatine injection drug. Date of state registration: 13.01.2012
05.03.2012
“Pharmassets” company gained permission for clinical researches of the Peginterferon alfa-2b medical preparation. Date of state registration: 17.08.2011
29.02.2012
“Pharmassets” company was allowed to gain permission for clinical researches of the Abacavir + Lamivudine tablet drug. Date of allowing: 08.11.2011
28.02.2012
“Pharmassets” company gained permission for clinical researches of the Meropenem injection drug. Date of state registration: 05.10.2011
22.02.2012
The "Pharmassets" company has successfully completed the procedure of state registration of the RANKOF medical preparation. For further information about registered preparations visit "Registered preparations" section.
20.02.2012
“Pharmassets” company gained permission for clinical researches of the Calcitonin nasal spray. Date of state registration: 13.10.2011
17.02.2012
“Pharmassets” company gained permission for clinical researches of the Anastrozole tablet drug. Date of state registration: 31.08.2011 For further information about registered preparations visit "Drugs" section.
29.12.2011
“Pharmassets” company wishes you marry Christmas and happy New Year!
May the New Year be your year of success, prosperity and fulfillment of deepest wishes, let it be joyful and happy, productive and successful. We wish you good physical and financial health, reliable partners and new professional victories.
21.11.2011
"Pharmassets" ltd. and "Pharmprotection" Federal State Unitary Enterprise Research and Production Center jointly won Ministry of Industry and Trade of Russian Federation tender on the development and implementation of a new drug Darunavir in Russia.
20.06.2011
“Pharmassets” Group of companies announces that Pegylated human recombinant interferon alpha-2b (Peginterferon alfa-2b) was filed to registration under “Peginferon – FA” test name. Learn more about the drugs in registration in "Drugs” section.
17.06.2011
The meeting with Biocon Limited Indian company was held. We discussed possibility of concluding distribution contract and opportunity of registration pharmaceuticals in Russia of the following nosology: transplantation (immunomodulators), statins, ophthalmology, hypolipidemic and other.
The parties discussed possible ways of fruitful cooperation and possibility of concluding distribution contract.
20.05.2011
“Pharmassets” company held negotiations with Sava Medica Limited (India), and made the decision on joint registration and production of more than 20 medicines, including Latanoprost, Calcitonin, Fluticasone etc.
11.05.2011
Our company held negotiations with Keshali LLC (Azerbaijan), and made the decision on joint registration and production of more than 10 medicines, including Erythropoietin, Betahistine, Oktokog alpha etc.
27.04.2011
“Pharmassets” group of companies reports that as of April 25, 2011, the group with partners started the registration of number of drugs including: Metformin, Meloxicam, Sildenafil, Risperidone and others which are planned to bring to market under their own brands in 2012. Learn more about the registered drugs can be in the “Projects in registration” section.
26.04.2011
“Pharmassets” company held negotiations with Chem-East Ltd. (Chemo group), where the decision on co-operation and registration of medicines was made.
19.01.2011
“Pharmassets” Russian company representatives visited Zhongshan Belling Biotechnology Co., Ltd. factory and held talks about cooperation on joint development, production and sales of medicines on Russian pharmaceutical market. The sides exchanged their development plans and agreed to sign the necessary agreements for further collaboration. “Pharmassets” company is grateful for the warm welcome and friendly atmosphere to the Zhongshan Belling Biotechnology Co., Ltd factory.
17.01.2011
“Pharmassets” Russian company representatives visited Kaiping Genuine Biochemical Pharmaceutical Co., Ltd plant in the city of Kaiping, China. The sides discussed cooperation issues and signed an exclusive contract for the two Chinese factory products. “Pharmassets” company is grateful for the warm welcome and friendly atmosphere to the Kaiping Genuine Biochemical Pharmaceutical Co., Ltd plant.
10.11.2010
“Pharmassets” company and «AMA PHARM» Hong Kong company signed contract about providing marketing consultations for production of medicines in China.
10.10.2010
“Pharmassets” company representatives visited CPhI Worldwide, Paris 2010 international pharmaceutical exhibition. During the event, contacts were established with more than 25 different manufacturers of pharmaceutical ingredients and finished dosage forms, including large Indian companies Parabolic Drugs Ltd, Shilpa Medicare Ltd, MSN Laboratories Ltd; and agreed conditions for joint cooperation.
29.09.2010
“Pharmassets” company and Taiwan Liposome Company (TLC) (www.tlcbio.com) had talks by teleconference about joint development, manufacture and implementation on the Russian pharmaceutical market of medicines based on liposomal technology with support of the “ROSNANO” Russian Corporation of Nanotechnologies. The sides discussed ways of implementing pharmacy projects and exchanged information about opportunities for joint cooperation.
27.09.2010
“Pharmassets” company and "Adelaide Export LLP" UK pharmaceutical corporation signed an exclusive agreement on joint development, manufacture and implementation on the Russian pharmaceutical market of medicines.
14.09.2010
“Pharmassets” сompany started negotiations with “NC PHARM” company (www.ncpharm.ru) and Testing Laboratory about the prospects of further development of cooperation on logistics, customs and certification issues, on the basis of warehouse in Europe`s largest logistics complex “North Domodedovo” (Moscow region), which combined with a common vision of “A” class warehouses. Currently "Pharmassets" have got the licensed pharmaceutical warehouse and maintenance contract with the "NC PHARM" company.
13.09.2010
“Pharmassets” сompany started negotiations with “Pharmtechnology” pharmaceutical factory, Belarus (pharmtechnology.info). The sides discussed ways of implementing projects in production and sales of finished medicines.
10.09.2010
“Pharmassets” сompany started negotiations with “Bioberica” pharmaceutical company, Spain (www.bioiberica.com). The sides discussed ways of implementing projects in production and sales of finished medicines.
04.09.2010
“Pharmassets” Company held negotiations with SCO Business Council, Kennesaw State University www.kennesaw.edu (Barry J.Morris, Ph.D.) and Svetlana Dambinova D.Sci, Ph.D (www.gracelaboratories.com, www.cisbiotech.com). The sides discussed ways of implementing pharmacy projects and exchanged information about opportunities for joint cooperation.
03.09.2010
“Pharmassets” сompany started negotiations with “Merck” pharmaceutical company (www.merck.com). The sides discussed ways of implementing pharmacy projects and exchanged information about opportunities for joint cooperation.
26.08.2010
“Pharmassets” сompany started negotiations with the CIPLA pharmaceutical company (India) www.cipla.com. The sides discussed ways of implementing pharmacy projects and exchanged information about opportunities for joint cooperation.
19.08.2010
“Pharmassets” company and Business Council of Shanghai Cooperation Organization (SCO Business Council) signed an agreement on cooperation in the field of pharmaceutical projects development that meet the interests of the SCO and the Russian Federation.
11.08.2010
“Pharmassets” Company held negotiations with the Business Council of Shanghai Cooperation Organization (SCO Business Council). The sides discussed ways of implementing projects in the state program of the pharmaceutical industry development in Russia and exchanged information about opportunities of joint cooperation. Sergey Kanavsky (Executive Secretary of the SCO Business Council) expressed interest in continuing the dialogue and development specific cooperation agreements.
09.08.2010
“Pharmassets” Company held negotiations with the Hua-Yuan corporation (China). The sides discussed ways of implementing pharmacy projects and exchanged information about opportunities of joint cooperation.
04.08.2010
PHARMASSETS company held negotiations with ROSNANO, the Russian Corporation of Nanotechnologies. The parties discussed the possibility of joint cooperation in the field of pharmaceutical projects implementation in the Russian Federation, based on "direct delivery" of drugs - Drug Delivery Systems. Roman Knyazev (ROSNANO Investment Manager) and Sergei Petukhov (ROSNANO associate) expressed interest in continuing the dialogue and making by PHARMASSETS concrete proposals for cooperation.
02.08.2010
PHARMASSETS company and "Foucan Sinda" Ltd. China pharmaceutical corporation signed an exclusive agreement on joint development, manufacture and implementation on the Russian pharmaceutical market of medicines. Also "Foucan Sinda” will be PHARMASSETS representative in China.
28.07.2010
The second meeting with CHINESE MEDICINE HEALTH PRODUCTSIMPORT AND EXPORT CHAMBER OF COMMERCE and Pharmaceutical Corporation “Foucan Sinda” China leadership took place In the “Pharmassets” company office. The parties agreed on terms and the text of the strategic cooperation agreement on joint development, production and sales on the Russian pharmaceutical market of medicines.
20.07.2010
PHARMASSETS company announces the beginning of the import substitution program in accordance with the Development Strategy of the pharmaceutical industry in the Russian Federation until 2020...
19.07.2010
PHARMASSETS company holds conversation with “Hetero Drugs Limited” company. The sides discussed ways of implementing the state program of development of Russian pharmaceutical industry and exchanged information about the possibilities of joint cooperation. The head of the representation Mr. Kavaldzhit S. Makkar expressed interest in continuing the conversation and developing concrete cooperation agreements.
15.07.2010
PHARMASSETS company holds conversation with representatives of CHINESE MEDICINE HEALTH PRODUCTS IMPORT AND EXPORT CHAMBER OF COMMERCE and the leadership of the pharmaceutical corporation “Foucan Sinda” Co. Ltd. China about cooperation on joint development, production and marketing of the Russian pharmaceutical market of medicines. The two sides exchanged development plans and agreed to sign the necessary agreements for further collaboration.
Director of the “Foucan Sinda” Co. Ltd. China, Mrs. Liu Syuehua noted the high interest of Chinese companies on joint cooperation in implementing the state program of development of pharmaceutical industry in Russia.
01.07.2010
PHARMASSETS company signs an exclusive distribution and technological contract with Novalek Pharmaceuticals Pvt. Ltd. about the joint development, manufacturing and marketing in the pharmaceutical market of medicines in Russia.
18.06.2010
PHARMASSETS company signs the General Agreement on cooperation in the development, research, production and sale of medicines with FSUE “Moscow endocrine factory”.
31.05.2010
PHARMASSETS company signs the General Agreement on cooperation in the development, research, production and sale of medicines with the FSUE SPA "Microgen".
31.03.2010
PHARMASSETS company completes defining a unified system of reporting group of companies.
|